Intrinsic Value

The intrinsic value of Pharmather Holdings Ltd (PHRM) under the Base Case is 0.037 CAD per share. Compared with the current market price of 0.055 CAD, the stock appears Overvalued by 32% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

PHRM Intrinsic Value
CA$0.037
Overvaluation 32%
Intrinsic Value
Price CA$0.055
P

PHRM is valued in line with its history. A premium of this size has been typical over the past 5 years.

Monitor PHRM
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value CA$0.03
Get notified when the price drops into your buy zone
Current Price CA$0.06
Intrinsic Value CA$0.04
Margin of Safety 20% CA$0.03
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to PHRM

Fundamental Analysis

What Pharmather Does

PharmaTher Holdings Ltd. is a specialty psychedelic pharmaceutical company, which engages in the research, development and commercialization of ketamine and novel microneedle patches for delivering psychedelics to treat neuropsychiatric, neurodegenerative, and pain disorders. The company is headquartered in Toronto, Ontario. The company went IPO on 2020-10-09. The firm develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes.

Headquarters
Canada CA
IPO date
Oct 9, 2020
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Pharmather Holdings Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one PHRM stock?

The intrinsic value for Pharmather Holdings Ltd (PHRM) under the Base Case is 0.037 CAD.

Is PHRM stock undervalued or overvalued?

Compared with the current market price of 0.055 CAD, the stock appears Overvalued by 32% .

Back to Top